TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Total cholesterol plasma level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LDL-cholesterol plasma level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HDL-cholesterol plasma level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inadequate end-to-end anastomosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade I-III anal incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Take home baby rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: PbrO(2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APGAR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance rate with MLPA testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: active cervical lateral flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disability outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Symptomatic, laboratory-confirmed influenza
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean femoral tunnel diameter increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean tibial tunnel diameter increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of web-based C-ACT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of ACT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for web-based version
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correction of haemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement of iron stores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visibility of the anterior gland
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclass correlation for nuclear opalescence (NO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclass correlation for nuclear colour (NC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclass correlation for cortical (C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclass correlation for posterior subcapsular (PSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refusal of biopsy without additional anesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: symptomatic MPE recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine-like attacks after PGE(2)
Endpoint domain: Adverse events/effects
Primary endpoint: Neuropathy Total Symptom Score-6 (NTSS-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Norfolk QOL-DN total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SkBF at the distal calf
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of amenorrheic women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endometrial hyperplasia
Endpoint domain: Adverse events/effects
Primary endpoint: Circulating DHEA-S and testosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maturation of vaginal cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: angiographic late lumen loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CAlv
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Delta R5-R20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: live-birth rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Plasma ascorbate level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Belatacept serum concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: change in axial elongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with waiting times
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: maximal brain infarct size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pain levels during RUG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total sitting time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged bouts of sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EDITS total scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with visual acuity ≥ 20/200
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with visual acuity ≥ 20/40
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical evidence of radiation maculopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acid reflux rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chiropractic expenditures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Chiropractic use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: partial pressure of arterial CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: end-tidal CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: denture plaque level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance of extensively hydrolysed casein formula
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: rate of increase in alveolar bone height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-72 of amlodipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom quantification score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PANSS negative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PANSS positive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PANSS total symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reperfusion within 90 minutes of hospital contact
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median D2B time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average plasma aldosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Na(+) ‐K(+) ‐ATPase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum NTx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-reports of fear and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinician ratings of global functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing rate of ulcers ≤ 5 cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average healing time for ulcers ≤ 5 cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DLQI scores post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: BIS50 values at time of LOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability and validity of final study data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAV (Percentage of Atherosclerotic Volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TAV (Total Atherosclerotic Volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pregnancy rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Objective disease recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: tolerance to pramipexole increases
Endpoint domain: Adverse events/effects
Primary endpoint: Personal concerns and difficulties following diagnosis
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 1-RM load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: isometric steadiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: force fluctuations during contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise tolerance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking cessation during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Glottal configuration and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial triglyceride concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: large VLDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total HDL particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sELAM‐1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: sVCAM‐1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: incidence of marker-positive acute coronary syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: final balloon diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: increases in CRP, IL-6 and IL1-Ra
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: modified Rodnan skin thickness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: incidence of SRC
Endpoint domain: Adverse events/effects
Primary endpoint: Probability of relapse-free survival at month 15
Endpoint domain: Mortality/survival
Primary endpoint: maximum vertical opening (MVO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anteroposterior mandibular movement (MAM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertical mandibular movement during mastication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kaplan-Meier survival at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Device-related infection events per patient-year
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative bleeding requiring surgery events per patient-year
Endpoint domain: Adverse events/effects
Primary endpoint: percentage diameter difference of the vessel after hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: TGF‐β serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood oxygen level-dependent signal decrease in hypothalamus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RE (Response Entropy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients who developed neutropenic infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tooth sensitivity (TS)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of malignant trophoblastic disease
Endpoint domain: Mortality/survival
Primary endpoint: overall healing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean quantitative analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of higher grade abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Very low-density-lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Viral set point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvements in psychiatric symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in coping behaviour
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvements in hardship
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: percentage of goal calories received
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Return to oral tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Passage of flatus or stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Positive rate of vascular endothelial growth factor (VEGF) expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Fewer hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fewer emergency department visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fewer episodes of poor asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change in total Unified Parkinson's Disease Rating Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum diazo bilirubin value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of bleeding/spotting episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in physical and/or mental energy
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: feelings of greater personal control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gastric emptying time (T(50))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric emptying time (T(100))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: intestinal bile salt levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: intestinal phospholipid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cost-effectiveness of disposable forceps
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Residual patient debris on reusable forceps
Endpoint domain: Adverse events/effects
Primary endpoint: Interval from rupture of membranes to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRV improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute respiratory infection
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of acute diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Fatigue measured by fall in power per stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute final reticulocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: LA volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LA diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PV diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: PCA bolus use on POD 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: residual space
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any Drug Effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stimulated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willing to Pay
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Bad Effects
Endpoint domain: Adverse events/effects
Endpoint subdomain: null
Primary endpoint: pseudarthrosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Spinal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rate of AS symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive subjective effects
Endpoint domain: Adverse events/effects
Primary endpoint: Balance effects
Endpoint domain: Adverse events/effects
Primary endpoint: Trunk extension endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg press strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thermal sensitivity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cefuroxime half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative stay duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total analgesic doses
Endpoint domain: Adverse events/effects
Primary endpoint: Composite cardiovascular disease endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Uptake of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Time to first perceptible pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPID24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TOTPAR24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standing balance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in spasticity scores (Modified Ashworth Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Improvement in disability scores (Disability Assessment Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in fingers position at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity rates of malignant tumours
Endpoint domain: Mortality/survival
Primary endpoint: Relative risk for gastric cancer
Endpoint domain: Mortality/survival
Primary endpoint: Yale‐Brown obsessive‐compulsive scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12- and 60-month survival estimates
Endpoint domain: Mortality/survival
Primary endpoint: binge eating days per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Yale-Brown Obsessive Compulsive Scale modified for Binge Eating (Y-BOCS-BE) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for secondary velopharyngeal management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sleep concerns
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: median duration of the examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: detection of diminutive adenomas (< 5mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Contrast sensitivity function curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sense of purpose and meaning in life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 30-day mortality after major bleed
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative disease incidence rate
Endpoint domain: Mortality/survival
Primary endpoint: Detection of advanced disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: self-care score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for multilayered format
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status